Phio Share Price
NASDAQ: PHIO | HealthcarePhio Stock Performance
Phio Share Price Chart
Phio Quarterly Profit & Loss
All figures in USD
Phio Annual Profit & Loss
All figures in USD
Phio Balance Sheet
All figures in USD Million
Phio Cash Flow
All figures in USD Million
Corporate Actions
About Phio
Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.
Phio Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.89 | $0.74 | -13.29% |
Oct 2026 | $1.00 | $0.86 | -17.50% |
Sep 2026 | $1.06 | $1.04 | -7.14% |
Aug 2026 | $1.10 | $1.12 | +8.74% |
Jul 2026 | $1.02 | $1.03 | +0.49% |
Jun 2026 | $1.10 | $1.02 | -8.07% |
May 2026 | $1.20 | $1.11 | -8.98% |
Apr 2026 | $1.28 | $1.23 | -1.21% |
Mar 2026 | $1.07 | $1.24 | +9.25% |
Feb 2026 | $0.97 | $1.14 | +11.27% |
Jan 2026 | $1.05 | $1.02 | -1.92% |
Dec 2025 | $1.25 | $1.04 | -18.75% |